• Explore /
  • Poster
  • / Phase 2 randomized study of rintatolimod following FOLFIRINOX in patients with locally advanced pancreatic adenocarcinoma.

Phase 2 randomized study of rintatolimod following FOLFIRINOX in patients with locally advanced pancreatic adenocarcinoma.

Abstract Poster

Authors

Kelsey Klute

Kelsey Klute

University of Nebraska Medical Center, Omaha, NE

Kelsey Klute , Vincent J. Picozzi , Nashat Gabrail , Michael A. Hollingsworth , Christopher McAleer , Diane Young , David Rodney Strayer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer - Local-Regional Disease

Clinical Trial Registration Number

NCT05494697

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS4214)

DOI

10.1200/JCO.2024.42.16_suppl.TPS4214

Abstract #

TPS4214

Poster Bd #

177a

Abstract Disclosures

Similar Posters

First Author: Nai-Jung Chiang

First Author: Changhoon Yoo

First Author: Syvart Dennen

First Author: Dong Ho Lee